Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Researchers find a digital silver lining in failed COVID-19 drug trial

Researchers find a digital silver lining in failed COVID-19 drug trial

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Current understanding of the link between COVID-19 and cardiovascular disease

Current understanding of the link between COVID-19 and cardiovascular disease

Automated method shows predictive power for COVID-19 in-hospital mortality

Automated method shows predictive power for COVID-19 in-hospital mortality

Scientists suggest a new approach to mitigating the collateral damage from antibiotics

Scientists suggest a new approach to mitigating the collateral damage from antibiotics

Antibiotics alone cannot prevent stunted growth in children, study finds

Antibiotics alone cannot prevent stunted growth in children, study finds

Dispensing of hydroxychloroquine and ivermectin in Australia jumped in first year of COVID

Dispensing of hydroxychloroquine and ivermectin in Australia jumped in first year of COVID

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Potential covalent SARS-CoV-2 spike protein inhibitors

Potential covalent SARS-CoV-2 spike protein inhibitors

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

COVID-19 associated mucormycosis cases in India

COVID-19 associated mucormycosis cases in India

Study demonstrates the potency of herbal medicines against Bartonella henselae

Study demonstrates the potency of herbal medicines against Bartonella henselae

COVID-19 first wave increased the sale of antibiotic formulations in India

COVID-19 first wave increased the sale of antibiotic formulations in India

Broad-spectrum antibiotic no more effective than placebo in preventing COVID-19 symptoms

Broad-spectrum antibiotic no more effective than placebo in preventing COVID-19 symptoms

What lessons have we learned over a year into the COVID-19 pandemic?

What lessons have we learned over a year into the COVID-19 pandemic?

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Are COVID-19 medications safe in pregnancy?

Are COVID-19 medications safe in pregnancy?

Investigators map how drugs were used on people hospitalized with COVID-19  infection

Investigators map how drugs were used on people hospitalized with COVID-19 infection